DK1052259T3 - Optisk aktivt aminopentanderivat - Google Patents
Optisk aktivt aminopentanderivatInfo
- Publication number
- DK1052259T3 DK1052259T3 DK99947940T DK99947940T DK1052259T3 DK 1052259 T3 DK1052259 T3 DK 1052259T3 DK 99947940 T DK99947940 T DK 99947940T DK 99947940 T DK99947940 T DK 99947940T DK 1052259 T3 DK1052259 T3 DK 1052259T3
- Authority
- DK
- Denmark
- Prior art keywords
- optically active
- disease
- composition
- aminopentane derivative
- active aminopentane
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP34775698A JP4499208B2 (ja) | 1998-10-29 | 1998-10-29 | 新規な光学活性アミノペンタン誘導体 |
PCT/JP1999/005729 WO2000026204A1 (fr) | 1998-10-29 | 1999-10-15 | Nouveau derive d'aminopentane optiquement actif |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1052259T3 true DK1052259T3 (da) | 2007-08-06 |
Family
ID=18392375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99947940T DK1052259T3 (da) | 1998-10-29 | 1999-10-15 | Optisk aktivt aminopentanderivat |
Country Status (17)
Country | Link |
---|---|
US (1) | US6391914B1 (ko) |
EP (1) | EP1052259B1 (ko) |
JP (1) | JP4499208B2 (ko) |
KR (1) | KR100603112B1 (ko) |
CN (1) | CN1131858C (ko) |
AT (1) | ATE360009T1 (ko) |
AU (1) | AU762995B2 (ko) |
CA (1) | CA2317036C (ko) |
DE (1) | DE69935849T2 (ko) |
DK (1) | DK1052259T3 (ko) |
ES (1) | ES2285861T3 (ko) |
HK (1) | HK1032585A1 (ko) |
HU (1) | HU228299B1 (ko) |
IL (1) | IL136977A0 (ko) |
PT (1) | PT1052259E (ko) |
SI (1) | SI20209A (ko) |
WO (1) | WO2000026204A1 (ko) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4691230B2 (ja) * | 2000-04-11 | 2011-06-01 | 株式会社フジモト・コーポレーション | 光学活性1−(ベンゾフラン−2−イル)−2−プロピルアミノペンタンの製造方法 |
JP4888751B2 (ja) * | 2001-09-14 | 2012-02-29 | 株式会社フジモト・コーポレーション | トリフルオロプロピルアミノペンタン誘導体及びその製造方法 |
JP4953040B2 (ja) * | 2001-09-19 | 2012-06-13 | 株式会社フジモト・コーポレーション | アポトーシス抑制剤 |
JP5030194B2 (ja) * | 2004-11-25 | 2012-09-19 | 国立大学法人九州大学 | 薬物依存症治療剤 |
KR101500022B1 (ko) * | 2007-06-21 | 2015-03-06 | 가부시키가이샤 후지모토 코포레이션 | 경피 또는 경점막 투여용 조성물 |
AU2014371437B2 (en) * | 2013-12-25 | 2020-01-30 | Fujimoto Co., Ltd. | Prophylactic and therapeutic agent for attention-deficit/hyperactivity disorder |
HUE050756T2 (hu) | 2014-12-05 | 2021-01-28 | Semmelweis Univ | Arilalkilamin vegyületek rák megelõzésében vagy kezelésében történõ alkalmazásra |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU207280B (en) * | 1986-09-25 | 1993-03-29 | Chinoin Gyogyszer Es Vegyeszet | Process for producing new phenyl-alkyl-amines and pharmaceutical compositions containing them |
HUT63579A (en) * | 1991-12-20 | 1993-09-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes |
JPH0859578A (ja) * | 1994-06-17 | 1996-03-05 | Taisho Pharmaceut Co Ltd | 置換フェニルアルキルアミン誘導体 |
AU747737B2 (en) | 1997-08-07 | 2002-05-23 | Fujimoto Co., Ltd. | Novel ethylamine derivatives |
-
1998
- 1998-10-29 JP JP34775698A patent/JP4499208B2/ja not_active Expired - Fee Related
-
1999
- 1999-10-15 SI SI9920013A patent/SI20209A/sl not_active IP Right Cessation
- 1999-10-15 CA CA002317036A patent/CA2317036C/en not_active Expired - Fee Related
- 1999-10-15 EP EP99947940A patent/EP1052259B1/en not_active Expired - Lifetime
- 1999-10-15 AT AT99947940T patent/ATE360009T1/de active
- 1999-10-15 IL IL13697799A patent/IL136977A0/xx not_active IP Right Cessation
- 1999-10-15 DK DK99947940T patent/DK1052259T3/da active
- 1999-10-15 HU HU0004667A patent/HU228299B1/hu not_active IP Right Cessation
- 1999-10-15 AU AU61241/99A patent/AU762995B2/en not_active Ceased
- 1999-10-15 US US09/581,747 patent/US6391914B1/en not_active Expired - Lifetime
- 1999-10-15 CN CN998018570A patent/CN1131858C/zh not_active Expired - Fee Related
- 1999-10-15 KR KR1020007007280A patent/KR100603112B1/ko not_active IP Right Cessation
- 1999-10-15 WO PCT/JP1999/005729 patent/WO2000026204A1/ja active IP Right Grant
- 1999-10-15 DE DE69935849T patent/DE69935849T2/de not_active Expired - Lifetime
- 1999-10-15 PT PT99947940T patent/PT1052259E/pt unknown
- 1999-10-15 ES ES99947940T patent/ES2285861T3/es not_active Expired - Lifetime
-
2001
- 2001-05-08 HK HK01103235A patent/HK1032585A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU762995B2 (en) | 2003-07-10 |
EP1052259A1 (en) | 2000-11-15 |
HUP0004667A2 (hu) | 2001-04-28 |
WO2000026204A1 (fr) | 2000-05-11 |
KR20010033756A (ko) | 2001-04-25 |
KR100603112B1 (ko) | 2006-07-20 |
HU228299B1 (en) | 2013-03-28 |
ATE360009T1 (de) | 2007-05-15 |
JP2000136187A (ja) | 2000-05-16 |
DE69935849D1 (de) | 2007-05-31 |
HK1032585A1 (en) | 2001-07-27 |
IL136977A0 (en) | 2001-06-14 |
AU6124199A (en) | 2000-05-22 |
JP4499208B2 (ja) | 2010-07-07 |
EP1052259A4 (en) | 2001-10-24 |
EP1052259B1 (en) | 2007-04-18 |
ES2285861T3 (es) | 2007-11-16 |
DE69935849T2 (de) | 2008-01-10 |
CN1287554A (zh) | 2001-03-14 |
CA2317036A1 (en) | 2000-05-11 |
CA2317036C (en) | 2009-05-19 |
PT1052259E (pt) | 2007-07-20 |
US6391914B1 (en) | 2002-05-21 |
CN1131858C (zh) | 2003-12-24 |
SI20209A (sl) | 2000-10-31 |
HUP0004667A3 (en) | 2001-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9914638A (pt) | Composto, método para a preparação do mesmo, composição farmacêutica, uso de um composto, e, método para o tratamento de um distúrbio ou doença de um corpo de animal vivo | |
MY138252A (en) | Azabicyclic-substitud fused-heteroaryl compounds for the treatment of disease | |
NO20063275L (no) | Anvendelse av substituerte 2-aminotetraliner for forebyggende behandling av Parkinsons sykdom | |
DK1780197T3 (da) | 5-Substituerede 2-phenylamino-benzamider som MEK-inhibitorer | |
EA200301216A1 (ru) | Замещенные хинуклидинами мультициклические гетероарилы для лечения заболевания | |
ES2196527T3 (es) | Derivados de 11,15-o-dialquilprostaglandina e, su procedimiento de produccion y medicamentos que incluyen estos como principio activo. | |
ATE260255T1 (de) | 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate | |
UY26813A1 (es) | Compuestos para tratar enfermedad de alzheimer | |
BG105112A (en) | Agents with antidepressive effect | |
PT669920E (pt) | 3-aminoalquilamino-1,2-benzoxazoles substituidos ecompostos relacionados | |
DE60012751D1 (de) | Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz | |
BR0206495A (pt) | Tratamento de distúrbios de cns empregando antagonistas de oxidase de d-aminoácido e oxidase de d-aspartato | |
PE20080364A1 (es) | Acido bifenilcarboxilicos substituidos y sus derivados como moduladores de la actividad de la gamma-secretasa | |
EA200300716A1 (ru) | Гетероциклилалкилиндольные или -азаиндольные соединения в качестве лиганд 5-гидрокситриптамина-6 | |
NO20021875L (no) | Fremgangsmåte for stabilisering av benzimidazolforbindelser | |
DE69835004D1 (de) | Neue ethylaminderivate | |
MX2009004898A (es) | Derivados de indol y de benzofurano-2-carboxamida. | |
DK1052259T3 (da) | Optisk aktivt aminopentanderivat | |
ATE523498T1 (de) | Hiv-inhibierende 2-(4- cyanophenylamino)pyrimidinderivate | |
BR0011728A (pt) | Método de inibir a agregação de proteìna amilóide e imagem de depósitos de amilóide | |
DK0966277T3 (da) | Anvendelse af R-NSAID'er til forebyggelse af Alzheimer's sygdom | |
DE60002583D1 (de) | Benzofurylpiperazine als serotonin-agonisten | |
DK1174131T3 (da) | Anvendelse af et middel til forbedring af astrocytfunktion til behandling af Parkinsons sygdom | |
BR0110871A (pt) | Derivados de sulfonamida | |
PT804186E (pt) | Compostos alcaloides diterpenicos de indole |